Written by Mark O'Neill
Learn how to prevent low blood sugar during workouts if you have diabetes. Discover the best exercises, when to eat carbs, how insulin affects your numbers, and how to use technology to stay safe while staying active.
Written by Mark O'Neill
Learn what you need to know when picking up generic medications. Understand therapeutic equivalence, why generics look different, how to spot safe options, and what to ask your pharmacist to ensure your medication works as intended.
Written by Mark O'Neill
Menopause weight gain isn't about overeating-it's hormonal shifts, muscle loss, and slower metabolism. Learn how to fight abdominal fat with protein, strength training, and sleep-not diets.
Written by Mark O'Neill
Learn what BID, TID, and PRN really mean on your prescription labels. Stop guessing your dosing schedule and avoid dangerous mistakes with clear, practical advice backed by medical research.
Written by Mark O'Neill
Hypoglycemia in older adults is a silent threat that increases fall risk, cognitive decline, and death. Learn why certain diabetes meds like glyburide are dangerous, how to spot hidden symptoms, and what prevention plans actually work.
Written by Mark O'Neill
The FDA monitors generic drugs after approval using real-time data, adverse event reports, and factory inspections to ensure ongoing safety. Learn how FAERS, Sentinel, and AI are helping catch hidden risks.
Written by Mark O'Neill
Computer Vision Syndrome causes eye strain, headaches, and dry eyes from prolonged screen use. Learn proven, science-backed ways to prevent it - from the 20-20-20 rule to screen positioning and eye exams.
Written by Mark O'Neill
Why your generic drug might cost more than the brand-name version - it's not about the medicine, it's about rebates. Learn how tiered copays work and what you can do to save money.
Written by Mark O'Neill
NTI generics require stricter regulation than regular generics due to their narrow safety margin. This article compares how the FDA, EMA, Health Canada, and Japan approve these high-risk drugs, and why global harmonization is critical for patient safety.
Written by Mark O'Neill
Bioequivalence studies must now reflect real-world patients. Learn how age and sex impact generic drug testing, what regulators require, and why balancing male and female participants is no longer optional.